India in Talks to Buy 50 Million Doses of Pfizer Vaccine
The Wall Street Journal reported on Wednesday that India is in talks to buy 50 million doses of Pfizer Inc’s COVID-19 vaccine from German partner BioNTech SE, citing people familiar with the subject.
The government has been depending primarily on the AstraZeneca vaccine made by the Serum Institute of India and a home-grown shot produced by Bharat Biotech, which launched one of the world’s largest vaccination efforts earlier this year.
Last week, the country approved Johnson &Johnson’s one-shot vaccine for emergency usage, joining the list of vaccines approved by AstraZeneca, Bharat Biotech, Russia’s Gamaleya Institute, and Moderna.
Pic Courtesy: google/ images are subject to copyright